Physician profile
Scott D Woogen
NPI 1215939251
$2,328.25
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $272 · 2021: $1,029 · 2022: $601 · 2023: $66.20 · 2024: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $670.80 | 2019-2024 | Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $555.51 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $333.85 | 2019-2022 | |
| Madrigal Pharmaceuticals | $108.93 | 2024 | Rezdiffra |
| Janssen Biotech, INC. | $93.89 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $85.49 | 2020-2021 | |
| Celgene Corporation | $79.40 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $67.69 | 2020-2021 | |
| Gilead Sciences, INC. | $63.41 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $47.15 | 2022 | |
| Evoke Pharma, INC. | $46.65 | 2021 | |
| Echosens North America, INC. | $39.68 | 2021-2024 | Fibroscan |
| Intercept Pharmaceuticals, INC. | $22.75 | 2019 | |
| Ucb, INC. | $20.61 | 2019 | |
| Nestle Healthcare Nutrition INC. | $18.89 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.93 | 2020 | |
| Braintree Laboratories, INC. | $14.97 | 2022 | |
| Tactile Systems Technology INC | $14.61 | 2023 | Entre Plus, Flexitouch Plus |
| Medicomp INC | $13.61 | 2023 | Telepatch Cardiac Monitor |
| Astrazeneca Pharmaceuticals LP | $13.43 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Woogen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.